Mitochondrial Toxicity of Tenofovir Dipivoxil Fumaratein HK-2 Cells

被引:0
|
作者
Luo, Qi-hui [1 ,3 ]
Zhao, Jun-jun [1 ,2 ]
Feng, Xing-lei [2 ]
Chen, Zheng-li [1 ,3 ]
Zeng, Wen [1 ,2 ]
Gong, Li [1 ,2 ]
Cheng, An-chun [1 ,3 ]
Shen, Yu-bo [2 ]
Zhu, Chun-mei [2 ]
机构
[1] Sichuan Agr Univ, Engn & Techonl Ctr Lab Anim, Yaan 625014, Peoples R China
[2] Sinopharm Ctr Safety Evaluat & Res, Chengdu 610051, Peoples R China
[3] Key Lab Anim Dis & Human Hlth Sichuan Prov, Yaan 625014, Peoples R China
关键词
REVERSE-TRANSCRIPTASE INHIBITORS; ANTIRETROVIRAL THERAPY; DISOPROXIL FUMARATE; LACTIC-ACIDOSIS; RHESUS-MONKEYS; DNA-POLYMERASE; TREATED RATS; HEPATITIS; DEPLETION; VIRUS;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Nucleoside analogs have been shown to have mitochondrial toxicity. In vitro tests can evaluate the mechanisms and severity of the toxicity. Tenofovir dipivoxil fumarate (TDF) is a novel drug for type B hepatitis. In this study, HK-2 cells were used to evaluate the effect of TDF on mitochondrial toxicity in the kidney. HK-2 cells were treated for 9 days in seven treatment groups. This study measured the inhibitory rate of cell proliferation, lactic acid levels, activities of mitochondrial respiratory chain complexes I-III, and mitochondrial DNA content as well as mitochondrial ultrastructure. Results exhibited that rates of cell proliferation, activities of complexes I, III and mitochondrial DNA content were reduced, but lactic acid levels increased in the 125 mu M TDF group. Mitochondrial ultrastructure was damaged in the 125 mu M TDF and 62.5 mu M TDF groups. Thus, the 125 mu M TDF group exhibited noticeable mitochondrial toxicity, whereas 62.5 mu M TDF presented weak mitochondrial toxicity, and 31.25 mu M TDF exhibited no obvious mitochondrial toxicity.
引用
收藏
页码:266 / 277
页数:12
相关论文
共 50 条
  • [21] Doxorubicin Cytotoxicity and Mitochondrial Changes in Human Proximal Tubular Epithelial Cells (HK-2) is Partially Prevented by Resveratrol
    Valentovic, Monica
    Brown, Kathleen
    Dial, Mason
    McGuffey, Rachel
    [J]. FASEB JOURNAL, 2021, 35
  • [22] Empagliflozin Protects HK-2 Cells from High Glucose-Mediated Injuries via a Mitochondrial Mechanism
    Lee, Wen-Chin
    Chau, You-Ying
    Ng, Hwee-Yeong
    Chen, Chiu-Hua
    Wang, Pei-Wen
    Liou, Chia-Wei
    Lin, Tsu-Kung
    Chen, Jin-Bor
    [J]. CELLS, 2019, 8 (09)
  • [23] DegradedPorphyra yezoensispolysaccharide protects HK-2 cells and reduces nano-COM crystal toxicity, adhesion and endocytosis
    Zhang, Hui
    Sun, Xin-Yuan
    Chen, Xue-Wu
    Ouyang, Jian-Ming
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (32) : 7233 - 7252
  • [24] Differential toxicity mechanism of gold nanoparticles in HK-2 renal proximal tubular cells and 786-0 carcinoma cells
    Zhao, Peipei
    Chen, Xiaojing
    Wang, Qiaoling
    Zou, Hanbing
    Xie, Yuexia
    Liu, Hongmei
    Zhou, Yan
    Liu, Peifeng
    Dai, Huili
    [J]. NANOMEDICINE, 2020, 15 (11) : 1079 - 1096
  • [26] HK-2 cells as a human model of renal organic anion transport
    Robertson, EE
    Kiningham, KK
    Rankin, GO
    [J]. FASEB JOURNAL, 2003, 17 (04): : A616 - A617
  • [27] Effects of Charged Oxime Reactivators on the HK-2 Cell Line in Renal Toxicity Screening
    Handl, Jiri
    Malinak, David
    Capek, Jan
    Andrys, Rudolf
    Rousarova, Erika
    Hauschke, Martina
    Bruckova, Lenka
    Cesla, Petr
    Rousar, Tomas
    Musilek, Kamil
    [J]. CHEMICAL RESEARCH IN TOXICOLOGY, 2021, 34 (03) : 699 - 703
  • [28] HG-Induced sEVs Mediate Biomechanics of HK-2 Cells
    Yang F.
    Wang J.
    Ju T.
    Wang S.
    Qu K.
    Song Z.
    Chen Y.
    Wang Z.
    [J]. Nanomanufacturing and Metrology, 2023, 6 (01)
  • [29] Analysis and Characterization of HK-2 Cells for High Throughput Drug Testing
    Sakolish, Courtney
    Reiss, Matthew
    Mahler, Gretchen
    [J]. 2013 39TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC 2013), 2013, : 233 - 234
  • [30] Oxidative stress induced by hyperglycaemia and angiotensin II in HK-2 cells
    Whittaker, L
    McArdle, F
    Jackson, MJ
    Vora, J
    Bone, M
    Rustom, R
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 : V237 - V237